发明名称 |
THERAPIES FOR IMPROVING PULMONARY FUNCTION |
摘要 |
The disclosure relates to IL-13 antagonists, in particular anti-human-IL-13 antibodies and human-IL-13-binding fragments thereof, and their use for improvement, maintenance or reduction in the rate of decline of pulmonary function in a subject with impaired pulmonary function, which may be associated with uncontrolled moderate-to-asthma, COPD or IPF.
|
申请公布号 |
US2013281876(A1) |
申请公布日期 |
2013.10.24 |
申请号 |
US201113879261 |
申请日期 |
2011.10.14 |
申请人 |
FAGGIONI RAFFAELLA;MAY RICHARD;KELL CHRIS;MOLFINO NESTER;ROSKOS LORIN;MEDIMMUNE LIMITED |
发明人 |
FAGGIONI RAFFAELLA;MAY RICHARD;KELL CHRIS;MOLFINO NESTER;ROSKOS LORIN |
分类号 |
A61B5/087;A61K39/395;A61K45/06 |
主分类号 |
A61B5/087 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|